NVCT (Nuvectis Pharma, Inc.) operates in the Health technology sector. It's currently trading at $19.15. Our composite momentum score rates it 65/110 based on price +5.4% (1d) — solid move, rvol 1.2x — above average volume, rsi 73.0 — overbought, roc9 +30.2% — sharp acceleration, macd 0.45 — bullish, beta 1.07 — above-market volatility, and analyst: strong buy. Up 52.1% across 2 tracked price points, from Jul 7, 2026 to Jul 7, 2026.